The final phase in acute myeloid leukaemia (AML). A study on bleeding, infection and pain
- PMID: 12648506
- DOI: 10.1016/s0145-2126(02)00262-x
The final phase in acute myeloid leukaemia (AML). A study on bleeding, infection and pain
Abstract
To increase the knowledge of the final phase of acute myeloid leukaemia (AML) a retrospective review of the medical and nursing records of 106 adult patients with AML who had died in 1995-1997 was made. A total of 27 patients were treated with curative intent at the time of death and 79 patients were prescribed palliative care. From the documentation, an evaluation of the frequency and severity of bleeding and pain episodes was made during their last week in life, and the occurrence of infection criteria was studied. Notations on bleeding were found in 44%, infection in 71% and pain in 76% of the patients. In 54% of the morphine administration days, no information on the effect of given morphine treatment was registered. To give AML patients in the final phase, the best possible treatment, skills in palliative medicine and palliative care are important.
Similar articles
-
The final phase in acute myeloid leukaemia (AML): a study of cause of death, place of death and type of care during the last week of life.Leuk Res. 2001 Aug;25(8):673-80. doi: 10.1016/s0145-2126(01)00005-4. Leuk Res. 2001. PMID: 11397472
-
[A "good death" needs to be discussed. A study of patients with acute myeloid leukemia demonstrates the value of palliative care].Lakartidningen. 2003 Dec 4;100(49):4072-7. Lakartidningen. 2003. PMID: 14717071 Swedish.
-
Dyspnea, relative youth and low daily doses of opioids predict increased opioid dosage in the last week of a terminal cancer patient's life.Jpn J Clin Oncol. 2014 Nov;44(11):1082-7. doi: 10.1093/jjco/hyu137. Epub 2014 Sep 23. Jpn J Clin Oncol. 2014. PMID: 25249380
-
End-of-life care: forensic medicine v. palliative medicine.J Law Med Ethics. 2003 Fall;31(3):365-76. doi: 10.1111/j.1748-720x.2003.tb00100.x. J Law Med Ethics. 2003. PMID: 14626545 Review. No abstract available.
-
Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidol.Expert Opin Drug Metab Toxicol. 2016 Jun;12(6):669-80. doi: 10.1080/17425255.2016.1179281. Epub 2016 Apr 29. Expert Opin Drug Metab Toxicol. 2016. PMID: 27081769 Review.
Cited by
-
Dying of hematologic patients--treatment characteristics in a German University Hospital.Support Care Cancer. 2012 Nov;20(11):2895-902. doi: 10.1007/s00520-012-1417-8. Epub 2012 Mar 13. Support Care Cancer. 2012. PMID: 22410860
-
Catastrophic bleeds during end-of-life care in haematology: controversies from Australian research.Support Care Cancer. 2009 May;17(5):527-37. doi: 10.1007/s00520-008-0506-1. Epub 2008 Sep 23. Support Care Cancer. 2009. PMID: 18810505
-
Hospice admissions for cancer in the final days of life: independent predictors and implications for quality measures.J Clin Oncol. 2014 Oct 1;32(28):3184-9. doi: 10.1200/JCO.2014.55.8817. Epub 2014 Aug 25. J Clin Oncol. 2014. PMID: 25154824 Free PMC article.
-
Symptom burden and supportive care in patients with acute leukemia.Leuk Res. 2013 Jul;37(7):731-6. doi: 10.1016/j.leukres.2013.02.009. Epub 2013 Mar 11. Leuk Res. 2013. PMID: 23490030 Free PMC article.
-
Pain in blood cancers.Indian J Palliat Care. 2011 Sep;17(3):175-83. doi: 10.4103/0973-1075.92333. Indian J Palliat Care. 2011. PMID: 22346041 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical